Cautionary considerations regarding N.O.T.E.S. in oncology

Abstract Over the last number of years, the emphasis in abdominal surgery has been to reduce invasiveness and to minimise trauma to the patient. This has led to the rapid development of laparoscopic techniques initially for the surgical management of benign disease and later for the successful manag...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Surgical oncology 2009-06, Vol.18 (2), p.105-109
1. Verfasser: O'Riordain, M.G
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 109
container_issue 2
container_start_page 105
container_title Surgical oncology
container_volume 18
creator O'Riordain, M.G
description Abstract Over the last number of years, the emphasis in abdominal surgery has been to reduce invasiveness and to minimise trauma to the patient. This has led to the rapid development of laparoscopic techniques initially for the surgical management of benign disease and later for the successful management of malignant disease. Laparoscopy has now been shown to provide significant benefits to the cancer patient, in particular the reduction of wound infection, herniation and pain. More recently, benefits have been demonstrated in earlier discharge from hospital and return to normal activity. Laparoscopy has therefore been accepted as at least a valid alternative to open surgery for most types of abdominal cancer. With the objective of reducing invasiveness even more, the last few years has seen a rapid expansion in the development of Natural Orifice Translumenal Endoscopic Surgery (NOTES). Currently, NOTES is still in the early stages of evolution but its potential uses in the field of cancer surgery are already being proposed. To develop NOTES to the stage that it will be safe, effective and widely available for the management of cancer patients represents a huge challenge ranging from the development of equipment and techniques to the demonstration of safety and efficacy in clinical trials as well as training and competence issues. It is still not clear whether these challenges will be surmounted so that NOTES becomes mainstream therapy. A period of ‘watchful waiting’ seems appropriate therefore for the uncommitted general surgeon in order that NOTES may be given time to prove compelling and convincing before its general uptake into routine practice.
doi_str_mv 10.1016/j.suronc.2008.12.007
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_733100140</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>1_s2_0_S0960740408001175</els_id><sourcerecordid>733100140</sourcerecordid><originalsourceid>FETCH-LOGICAL-c444t-18ece7040b664dd0fe2d6b492f3f3c7c056ac7b89f903e557a737f582e37bfc13</originalsourceid><addsrcrecordid>eNqFkU9r2zAYh0XZaLNu32AUww49WXtlyZLdQ2GErhuE5dDuLGT5dVDmSK0UD_LtK5NAoZeeBOL5vX-el5CvDCgDJr9vaZpi8JZWAA1lFQVQZ2TBGtWWnFfwgSyglVAqAeKCfEppCwBSVeycXLCW85apekFulmbau-BNPBQ2-OR6jGb-SEXEjYm985viD13TR3pHH2jhfJF7hjFsDp_Jx8GMCb-c3kvy9-fd4_JXuVrf_17-WJVWCLEvWYMWFQjopBR9DwNWvexEWw184FZZqKWxqmvaoQWOda2M4mqomwq56gbL-CW5PtZ9iuF5wrTXO5csjqPxGKakFecMgAnI5Lc35DZM0efhNANeM8lkPVPiSNkYUoo46KfodllAhvSsVm_1Ua2e1WpW6aw2x65Oxaduh_1r6OQyA7dHALOM_w6jTtaht9i7iHav--De6_C2gB2dd9aM__CA6XUXnXJAP8znna8LTV5_nuAFZ2aexA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1035161650</pqid></control><display><type>article</type><title>Cautionary considerations regarding N.O.T.E.S. in oncology</title><source>MEDLINE</source><source>Access via ScienceDirect (Elsevier)</source><creator>O'Riordain, M.G</creator><creatorcontrib>O'Riordain, M.G</creatorcontrib><description>Abstract Over the last number of years, the emphasis in abdominal surgery has been to reduce invasiveness and to minimise trauma to the patient. This has led to the rapid development of laparoscopic techniques initially for the surgical management of benign disease and later for the successful management of malignant disease. Laparoscopy has now been shown to provide significant benefits to the cancer patient, in particular the reduction of wound infection, herniation and pain. More recently, benefits have been demonstrated in earlier discharge from hospital and return to normal activity. Laparoscopy has therefore been accepted as at least a valid alternative to open surgery for most types of abdominal cancer. With the objective of reducing invasiveness even more, the last few years has seen a rapid expansion in the development of Natural Orifice Translumenal Endoscopic Surgery (NOTES). Currently, NOTES is still in the early stages of evolution but its potential uses in the field of cancer surgery are already being proposed. To develop NOTES to the stage that it will be safe, effective and widely available for the management of cancer patients represents a huge challenge ranging from the development of equipment and techniques to the demonstration of safety and efficacy in clinical trials as well as training and competence issues. It is still not clear whether these challenges will be surmounted so that NOTES becomes mainstream therapy. A period of ‘watchful waiting’ seems appropriate therefore for the uncommitted general surgeon in order that NOTES may be given time to prove compelling and convincing before its general uptake into routine practice.</description><identifier>ISSN: 0960-7404</identifier><identifier>EISSN: 1879-3320</identifier><identifier>DOI: 10.1016/j.suronc.2008.12.007</identifier><identifier>PMID: 19339175</identifier><language>eng</language><publisher>Netherlands: Elsevier Ltd</publisher><subject>Cholecystectomy ; Clinical Competence ; Endoscopy - education ; Endoscopy - methods ; Endoscopy - standards ; Hematology, Oncology and Palliative Medicine ; Humans ; Laparoscopy ; Medical Oncology - instrumentation ; Medical Oncology - methods ; Medical Oncology - standards ; Neoplasms - surgery ; Oncology ; Safety ; Surgery ; Surgical Oncology</subject><ispartof>Surgical oncology, 2009-06, Vol.18 (2), p.105-109</ispartof><rights>Elsevier Ltd</rights><rights>2009 Elsevier Ltd</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c444t-18ece7040b664dd0fe2d6b492f3f3c7c056ac7b89f903e557a737f582e37bfc13</citedby><cites>FETCH-LOGICAL-c444t-18ece7040b664dd0fe2d6b492f3f3c7c056ac7b89f903e557a737f582e37bfc13</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.suronc.2008.12.007$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,780,784,3550,27924,27925,45995</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/19339175$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>O'Riordain, M.G</creatorcontrib><title>Cautionary considerations regarding N.O.T.E.S. in oncology</title><title>Surgical oncology</title><addtitle>Surg Oncol</addtitle><description>Abstract Over the last number of years, the emphasis in abdominal surgery has been to reduce invasiveness and to minimise trauma to the patient. This has led to the rapid development of laparoscopic techniques initially for the surgical management of benign disease and later for the successful management of malignant disease. Laparoscopy has now been shown to provide significant benefits to the cancer patient, in particular the reduction of wound infection, herniation and pain. More recently, benefits have been demonstrated in earlier discharge from hospital and return to normal activity. Laparoscopy has therefore been accepted as at least a valid alternative to open surgery for most types of abdominal cancer. With the objective of reducing invasiveness even more, the last few years has seen a rapid expansion in the development of Natural Orifice Translumenal Endoscopic Surgery (NOTES). Currently, NOTES is still in the early stages of evolution but its potential uses in the field of cancer surgery are already being proposed. To develop NOTES to the stage that it will be safe, effective and widely available for the management of cancer patients represents a huge challenge ranging from the development of equipment and techniques to the demonstration of safety and efficacy in clinical trials as well as training and competence issues. It is still not clear whether these challenges will be surmounted so that NOTES becomes mainstream therapy. A period of ‘watchful waiting’ seems appropriate therefore for the uncommitted general surgeon in order that NOTES may be given time to prove compelling and convincing before its general uptake into routine practice.</description><subject>Cholecystectomy</subject><subject>Clinical Competence</subject><subject>Endoscopy - education</subject><subject>Endoscopy - methods</subject><subject>Endoscopy - standards</subject><subject>Hematology, Oncology and Palliative Medicine</subject><subject>Humans</subject><subject>Laparoscopy</subject><subject>Medical Oncology - instrumentation</subject><subject>Medical Oncology - methods</subject><subject>Medical Oncology - standards</subject><subject>Neoplasms - surgery</subject><subject>Oncology</subject><subject>Safety</subject><subject>Surgery</subject><subject>Surgical Oncology</subject><issn>0960-7404</issn><issn>1879-3320</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2009</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkU9r2zAYh0XZaLNu32AUww49WXtlyZLdQ2GErhuE5dDuLGT5dVDmSK0UD_LtK5NAoZeeBOL5vX-el5CvDCgDJr9vaZpi8JZWAA1lFQVQZ2TBGtWWnFfwgSyglVAqAeKCfEppCwBSVeycXLCW85apekFulmbau-BNPBQ2-OR6jGb-SEXEjYm985viD13TR3pHH2jhfJF7hjFsDp_Jx8GMCb-c3kvy9-fd4_JXuVrf_17-WJVWCLEvWYMWFQjopBR9DwNWvexEWw184FZZqKWxqmvaoQWOda2M4mqomwq56gbL-CW5PtZ9iuF5wrTXO5csjqPxGKakFecMgAnI5Lc35DZM0efhNANeM8lkPVPiSNkYUoo46KfodllAhvSsVm_1Ua2e1WpW6aw2x65Oxaduh_1r6OQyA7dHALOM_w6jTtaht9i7iHav--De6_C2gB2dd9aM__CA6XUXnXJAP8znna8LTV5_nuAFZ2aexA</recordid><startdate>20090601</startdate><enddate>20090601</enddate><creator>O'Riordain, M.G</creator><general>Elsevier Ltd</general><general>Elsevier Limited</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QO</scope><scope>8FD</scope><scope>FR3</scope><scope>K9.</scope><scope>P64</scope><scope>7X8</scope></search><sort><creationdate>20090601</creationdate><title>Cautionary considerations regarding N.O.T.E.S. in oncology</title><author>O'Riordain, M.G</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c444t-18ece7040b664dd0fe2d6b492f3f3c7c056ac7b89f903e557a737f582e37bfc13</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2009</creationdate><topic>Cholecystectomy</topic><topic>Clinical Competence</topic><topic>Endoscopy - education</topic><topic>Endoscopy - methods</topic><topic>Endoscopy - standards</topic><topic>Hematology, Oncology and Palliative Medicine</topic><topic>Humans</topic><topic>Laparoscopy</topic><topic>Medical Oncology - instrumentation</topic><topic>Medical Oncology - methods</topic><topic>Medical Oncology - standards</topic><topic>Neoplasms - surgery</topic><topic>Oncology</topic><topic>Safety</topic><topic>Surgery</topic><topic>Surgical Oncology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>O'Riordain, M.G</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Biotechnology Research Abstracts</collection><collection>Technology Research Database</collection><collection>Engineering Research Database</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>Surgical oncology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>O'Riordain, M.G</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Cautionary considerations regarding N.O.T.E.S. in oncology</atitle><jtitle>Surgical oncology</jtitle><addtitle>Surg Oncol</addtitle><date>2009-06-01</date><risdate>2009</risdate><volume>18</volume><issue>2</issue><spage>105</spage><epage>109</epage><pages>105-109</pages><issn>0960-7404</issn><eissn>1879-3320</eissn><abstract>Abstract Over the last number of years, the emphasis in abdominal surgery has been to reduce invasiveness and to minimise trauma to the patient. This has led to the rapid development of laparoscopic techniques initially for the surgical management of benign disease and later for the successful management of malignant disease. Laparoscopy has now been shown to provide significant benefits to the cancer patient, in particular the reduction of wound infection, herniation and pain. More recently, benefits have been demonstrated in earlier discharge from hospital and return to normal activity. Laparoscopy has therefore been accepted as at least a valid alternative to open surgery for most types of abdominal cancer. With the objective of reducing invasiveness even more, the last few years has seen a rapid expansion in the development of Natural Orifice Translumenal Endoscopic Surgery (NOTES). Currently, NOTES is still in the early stages of evolution but its potential uses in the field of cancer surgery are already being proposed. To develop NOTES to the stage that it will be safe, effective and widely available for the management of cancer patients represents a huge challenge ranging from the development of equipment and techniques to the demonstration of safety and efficacy in clinical trials as well as training and competence issues. It is still not clear whether these challenges will be surmounted so that NOTES becomes mainstream therapy. A period of ‘watchful waiting’ seems appropriate therefore for the uncommitted general surgeon in order that NOTES may be given time to prove compelling and convincing before its general uptake into routine practice.</abstract><cop>Netherlands</cop><pub>Elsevier Ltd</pub><pmid>19339175</pmid><doi>10.1016/j.suronc.2008.12.007</doi><tpages>5</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0960-7404
ispartof Surgical oncology, 2009-06, Vol.18 (2), p.105-109
issn 0960-7404
1879-3320
language eng
recordid cdi_proquest_miscellaneous_733100140
source MEDLINE; Access via ScienceDirect (Elsevier)
subjects Cholecystectomy
Clinical Competence
Endoscopy - education
Endoscopy - methods
Endoscopy - standards
Hematology, Oncology and Palliative Medicine
Humans
Laparoscopy
Medical Oncology - instrumentation
Medical Oncology - methods
Medical Oncology - standards
Neoplasms - surgery
Oncology
Safety
Surgery
Surgical Oncology
title Cautionary considerations regarding N.O.T.E.S. in oncology
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-24T21%3A28%3A49IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Cautionary%20considerations%20regarding%20N.O.T.E.S.%20in%20oncology&rft.jtitle=Surgical%20oncology&rft.au=O'Riordain,%20M.G&rft.date=2009-06-01&rft.volume=18&rft.issue=2&rft.spage=105&rft.epage=109&rft.pages=105-109&rft.issn=0960-7404&rft.eissn=1879-3320&rft_id=info:doi/10.1016/j.suronc.2008.12.007&rft_dat=%3Cproquest_cross%3E733100140%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1035161650&rft_id=info:pmid/19339175&rft_els_id=1_s2_0_S0960740408001175&rfr_iscdi=true